CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The BioGuidePCa project aims to validate biomarkers for prostate cancer management, focusing on active surveillance and the early detection of metastatic disease. It seeks to develop non-invasive urine tests to monitor cancer progression and guide personalized treatment strategies.
The BioGuidePCa project is designed to validate previously reported biomarkers for prostate cancer (PCa) management during surveillance of early and advanced PCa.
With availability of PSA-screening an increase of insignificant PCa has been observed leading to over-diagnosis and overtreatment.
Consequently active surveillance (AS) is an alternative to immediate therapy. AS is expectant management with curative intervention only for those patients with local tumor progression.
Neuhaus et. al repor…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
